HUP9902713A2 - Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers - Google Patents

Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers

Info

Publication number
HUP9902713A2
HUP9902713A2 HU9902713A HUP9902713A HUP9902713A2 HU P9902713 A2 HUP9902713 A2 HU P9902713A2 HU 9902713 A HU9902713 A HU 9902713A HU P9902713 A HUP9902713 A HU P9902713A HU P9902713 A2 HUP9902713 A2 HU P9902713A2
Authority
HU
Hungary
Prior art keywords
fragments
antigen binding
antigen
antibody
prophylaxis
Prior art date
Application number
HU9902713A
Other languages
Hungarian (hu)
Inventor
Michael D. Dan
Howard A. Kaplan
Pradip K. Maiti
Original Assignee
Novopharm Biotech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novopharm Biotech, Inc. filed Critical Novopharm Biotech, Inc.
Priority to HU9902713A priority Critical patent/HUP9902713A3/en
Publication of HUP9902713A2 publication Critical patent/HUP9902713A2/en
Publication of HUP9902713A3 publication Critical patent/HUP9902713A3/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A novel composition comprises an antigen binding fragment of an antibody (Ab) which specifically recognises C-antigen, where C-antigen is the antigen specifically recognised by an antibody comprising a heavy (H) chain variable (V) region (VH) having a 179 residue sequence and a light (L) chain V region (VL) having a 150 residue sequence. Both sequences are given in the specification. Also claimed are: (1) a polypeptide comprising at least 5 consecutive amino acids of VH or VL, preferably from a CDR; (2) a humanised antibody comprising the polypeptide of (1); (3) a polymeric peptide comprising a number of peptides as in (1); (4) a polynucleotide sequence (I) encoding an antigen binding fragment of an antibody as above; (5) a polynucleotide encoding the polypeptide of (1); (6) a vector containing (I); and (7) a host cell containing (I).
HU9902713A 1997-05-22 1997-05-22 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers HUP9902713A3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU9902713A HUP9902713A3 (en) 1997-05-22 1997-05-22 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9902713A HUP9902713A3 (en) 1997-05-22 1997-05-22 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers

Publications (2)

Publication Number Publication Date
HUP9902713A2 true HUP9902713A2 (en) 1999-12-28
HUP9902713A3 HUP9902713A3 (en) 2000-12-28

Family

ID=89999022

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9902713A HUP9902713A3 (en) 1997-05-22 1997-05-22 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers

Country Status (1)

Country Link
HU (1) HUP9902713A3 (en)

Also Published As

Publication number Publication date
HUP9902713A3 (en) 2000-12-28

Similar Documents

Publication Publication Date Title
Terhorst et al. The primary structure of an acidic protein from 50‐S ribosomes of Escherichia coli which is involved in GTP hydrolysis dependent on elongation factors G and T
CA2164984A1 (en) Recombinant disulfide-stabilized polypeptide fragments having binding specificity
BG112042A (en) Human antibodies binding human tumor necrosis factor alpha (tnf alpha)
AU4778101A (en) Novel polypeptides, and nucleic acids encoding the same
WO1998037200A3 (en) Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies
HK1142272A1 (en) Specific binding proteins and uses thereof
WO2002008293A3 (en) Multivalent target binding protein
WO2000037638A3 (en) Methods and compositions for inhibiting neoplastic cell growth
EP1862472A3 (en) Chlamydia protein, gene sequence and uses thereof
NZ336929A (en) Purified receptor that binds TRAIL and antibodies thereof
BG102983A (en) Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application
WO1998033919A3 (en) Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use
BR9809778A (en) Isolated polynucleotide, expression vector, isolated peptide or polypeptide, antibody, process for producing the same, antibody fragments, single chain antibodies or humanized antibodies, and anti-idiotypic antibody.
Müller et al. The location of disulphide bonds in α-type gliadins
WO2000026244A3 (en) A novel tumor necrosis factor family member, drl, and related compositions and methods
HUP9902713A2 (en) Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
WO1994011509A3 (en) Peptides and anti-sense peptides with broad neoplastic specificity
WO2000032778A3 (en) Methods and compositions for inhibiting neoplastic cell growth
DE69328114D1 (en) Peptide als diagnose- und therapiemittel für spondyloarthropathien
WO2002002625A3 (en) Novel fibroblast growth factors and nucleic acids encoding same
DE59813388D1 (en) Polypeptides having amino acid sequences from the N-terminal region of cytomegalovirus gp116 and their use in diagnostics, prophylaxis and therapy
NZ505866A (en) V196 (also known as RAMP2) DNA and polypeptides
NZ509417A (en) Novel peptides for use in immunotherapy of autoimmune diseases
WO2001036644A3 (en) Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
EP2075335A3 (en) Methods and compositions for inhibiting neoplastic cell growth

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees